MedPath

To study management of ayurvedic formulation in generalized anxiety disorder.

Phase 2
Conditions
Health Condition 1: F411- Generalized anxiety disorder
Registration Number
CTRI/2024/05/067179
Lead Sponsor
Dr. Nilang Rajnikant Bhimani
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients fulfilling the diagnostic criteria for the Anxiety Disorders as per DSM 5

Age group - between 18 years to 70 years.

Voluntarily participation in the clinical trial and agreeing to follow study procedures

Not participating in any other interventional drug clinical studies before completion of the present study.

Exclusion Criteria

Inability to intake or tolerate oral medications

Pregnant or lactating women

Patients with current or has a history of substance use disorder

Patients having severe renal or hepatic impairment

Patients who displayed marked suicidal intent or known suicidal tendencies

Patient suffering from any psychiatric disorder other than GAD.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath